KOMBOGLYZE

This brand name is authorized in Austria, Canada, Cyprus, Estonia, Finland, France, Ireland, Lithuania, Poland, Romania, Spain, UK.

Active ingredients

The drug KOMBOGLYZE contains a combination of these active pharmaceutical ingredients (APIs):

1	Saxagliptin UNII Z8J84YIX6L - SAXAGLIPTIN HYDROCHLORIDE
	Saxagliptin is a highly potent (Ki: 1.3 nM), selective, reversible, competitive, DPP4 inhibitor. Saxagliptin improves glycaemic control by reducing fasting and postprandial glucose concentrations in patients with type 2 diabetes.
	Read more about Saxagliptin
2	Metformin UNII 786Z46389E - METFORMIN HYDROCHLORIDE
	Metformin is a biguanide with antihyperglycaemic effects, lowering both basal and postprandial plasma glucose. It does not stimulate insulin secretion and therefore does not produce hypoglycaemia.
	Read more about Metformin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
KOMBOGLYZE Film-coated tablet	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
A10BD10	Metformin and saxagliptin	A Alimentary tract and metabolism → A10 Drugs used in diabetes → A10B Blood glucose lowering drugs, excl. insulins → A10BD Combinations of oral blood glucose lowering drugs
Discover more medicines within A10BD10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
CA	Health Products and Food Branch	02389169, 02389177, 02389185
EE	Ravimiamet	1550258, 1550269, 1550270, 1550281, 1550292, 1550304, 1550315, 1550326, 1550337, 1550348, 1595392, 1595415
ES	Centro de información online de medicamentos de la AEMPS	11731002, 11731008
FI	Lääkealan turvallisuus- ja kehittämiskeskus	041281, 112566, 134199
FR	Base de données publique des médicaments	68674913
GB	Medicines & Healthcare Products Regulatory Agency	217054, 217057, 381441
IE	Health Products Regulatory Authority	16739, 16768
LT	Valstybinė vaistų kontrolės tarnyba	1064103, 1064104, 1064105, 1064106, 1064107, 1064108, 1064109, 1064110, 1064111, 1064112, 1064113, 1064114, 1067965, 1067966
PL	Rejestru Produktów Leczniczych	100261594, 100261602
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W62421001, W62421002, W62421003, W62421004, W62421005, W62421006, W62421007